The Sacred Mushroom™ (“TSM”) is Oregon’s one-of-a-kind psilocybin center. At 11,000 square feet, our large space provides our guests with the perfect setting, comfort, activities, and support necessary for a safe and meaningful psilocybin experience.

Whether guests come to explore the magic of psilocybin or to find peace and relief from a mental health disorder, our experienced facilitators and dedicated staff expertly guide visitors through their journey, fully leveraging our space and amenities to deliver a superior experience.

The Potential Market for Psilocybin Treatment

The United States and the world at large are currently undergoing a mental healthcare crisis. Consider the following data for the United States:

• • • • • • • 46,494,000 American adults (18%) battle an anxiety disorder such as Post Traumatic Stress Disorder, Panic Disorder, Obsessive Compulsive Disorder, and generalized anxiety disorder.
            • 24,538,500 American adults (9.5%) suffer from a depressive illness.
            • 17,306,100 American adults (6.7%) have been diagnosed with Alcohol Use Disorder.
            • 18,339,300 American adults (7.1%) are classified as drug dependent.
            • 11,416,860 American women (8.5 %) and 3,099,600 American men (2.5%) struggle with an eating disorder.
            • A suicide occurs every 11 minutes, including roughly 22 U.S. veterans every day.

The crisis is overwhelming healthcare systems, accentuating the need for new therapeutic approaches.

The Science of Psilocybin

Growing evidence suggests that psychedelics act on the brain’s default network, or those regions of the brain that remain active when your brain is not engaged in active tasks.

The default network provides a “framework” for the brain’s activity, providing structure and making order of all that is happening in the cortex and keeping external neurological information (delivered via our senses) distinct from internally generated activity (thoughts, emotions, and memory).

Psychedelics seem to suppress the default network, relaxing the separation of our senses, memories, thoughts, and emotions, and enabling each to influence each other more easily.This allows for a neuroplasticity, or a loosening of rigid neural pathways associated with trauma and a subsequent reduction of fear responses while enabling deep emotional processing.

This disruption of the default network, and the neuroplasticity it enables, offers an individual alternative way to process traumatic events and supports the formation of healthier cognitive patterns, potentially leading to improved mental health outcomes.

Petri et al, “Homological Scaffolds of Brain Functional Networks 

Journal of Royal Society Interface, Vol II, no.101, Dec. 2014

The Disruptive Nature of Psilocybin

The mental health industry needs disruptive new treatments. There is a global mental health crisis, to which existing therapeutic approaches and pharmaceuticals have proven insufficient and overwhelmed.

Psilocybin, and other psychedelics, promote neuroplasticity, loosening the rigid neural pathways associated with trauma – reducing fear responses, and enabling deep emotional processing. By doing so, it offers alternative ways to process traumatic events and supports the formation of healthier cognitive patterns, potentially leading to improved mental health outcomes.

According to Grand View Research, the increasing acceptance of psilocybin as part of a positive mental health and wellbeing routine is expected to drive growth in the psychedelics mushroom market, (inclusive of natural mushrooms, pharmaceuticals, and delivery of care) to $4.32 billion in 2030,

(https://www.grandviewresearch.com/industry-analysis/us-psychedelic-mushroom-market-report).

Of the revenue anticipated by the psychedelic mushrooms market, almost 75% will be created primarily by Delivery of Care Treatment Centers like The Sacred Mushroom™.

No Current Access to Breakthrough Therapies from Big Pharma

Companies such as Compass Pathways, ATAI Life Sciences, and Cybin are engaged in developing synthetic versions of psilocybin and psilocin, to offer as breakthrough therapies for treatment resistant mental health disorders. The expected distribution network for these companies are the Psilocybin Treatment Centers. The Sacred Mushroom™ looks forward to being able to offer our guests their products, once approved by the FDA and the relevant Oregon state regulators.

TSM’s Distinctive Business Model

KAYS has leveraged its unique operating history in Oregon to develop and launch The Sacred Mushroom™, an Oregon Health Authority (“OHA”) Licensed Psilocybin Service Center. We opened our doors in September of 2024 and immediately began providing immediate access to psilocybin-based mental health therapies in a carefully controlled safe environment.

The TSM business model embraces community, and the benefits derived from experiencing psilocybin as part of a group. Our low-dose psilocybin program “Community, Culture, & a Touch of Psilocybin” brings together like-minded people to explore psilocybin as part of a special evening celebrating the works of various artists, musicians, authors, and poets.

The program serves to broaden the market, makes the cost of treatment accessible, and lowers our operational expenses.

 In addition to serving groups and individuals seeking to interact with psilocybin, the Company is pursuing cooperation agreements with select pharmaceutical companies seeking access to data and a facility to host their trials.

Our E-Book Series

TSM has launched a series of E-Books aimed to deepen public understanding of psilocybin therapy and its potential to address a wide range of mental health and wellness needs. The first of this series, “Is Psilocybin Right for You”? was released in September 2024.

The second in the series “Comparing Psychedelics as Treatment Options” is set for release in February 2025.